FDA’s Cancer Advisory Committee to evaluate safety of P13K inhibitors
April 21, 2022Business Services
The FDA’s Oncologic Drugs Advisory Committee is holding a meeting today to discuss safety findings across the entire class of …
PacBio and Children’s Mercy Kansas City expand collaboration in rare disease
April 21, 2022Business Services
PacBio has announced an expanded research collaboration with Children’s Mercy Kansas City, to use the multi-omics capabilities of PacBio’s Sequel …
New Programme to tackle health disparities and inequalities for women with heart failure
April 21, 2022Business Services
Women diagnosed with heart failure have worse outcomes compared to men, in spite of a similar prevalence of the chronic …
Takeda Nuvaxovid COVID-19 vaccine approved in Japan
April 20, 2022Research and Development
Takeda’s Nuvaxovid Intramuscular Injection (Nuvaxovid) has been approved by the Japan Mnistry of Health, Labour and Welfare (MHLW). This is …
Care to Collaborate: Cydar Medical announces partnership with Medtronic
April 20, 2022Research and Development
Cydar Medical has announced a strategic collaboration with leading healthcare technology company Medtronic. Under the pilot arrangement, Cydar’s EV Maps …
Study initiated for first miniaturised robotic-assisted surgery platform
April 20, 2022Research and Development
Virtual Incision Corporation has announced the FDA approval of an Investigational Device Exemption (IDE) supplement to complete the final stage …
NHS Health Chief calls for return of facemasks and social distancing
April 20, 2022Research and Development
Chris Hopson, Chief Executive of NHS Providers, which represents trusts has urged ministers to discuss “sensible precautions” for the public, …
AstraZeneca drug granted FDA Priority Review
April 19, 2022Manufacturing and Production
AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …
FDA accept New Drug Application for GSK’s daprodustat
April 19, 2022Manufacturing and Production
GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …
VistaGen and AffaMed complete regulatory submissions for Phase III SAD trial
April 13, 2022Research and Development
VistaGen and AffaMed have announced the completion of key regulatory preparations to initiate PALISADE global, a Phase III clinical trial …
NICE recommends avelumab for urothelial cancer patients
April 13, 2022Research and Development
NICE has recommended avelumab as treatment for adults with locally advanced or metastatic urothelial cancer.The treatment, avelumab, will benefit over …
FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall
April 13, 2022Research and Development
The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II …
It could take up to six years to clear the patient backlog in Europe
April 13, 2022Research and Development
Research has found that oncologists and surgeons across Europe estimate it will take at least three years to clear the …
Tjaopack announces completion of Netherlands facility expansion
April 12, 2022Manufacturing and Production
Tjaopack has announced the completion of its expansion plans, following a €10 million plus investment, at its Etten-Leur facility in …
Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs
April 12, 2022Manufacturing and Production
NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …
VR solution for personalised treatment and surgery guidance to spine surgeons
April 12, 2022Manufacturing and Production
Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …
SMC accepts Inrebic for treatment of splenomegaly and myelofibrosis
April 12, 2022The SMC has accepted Inrebic (fedratinib) for use witin NHS Scotland, for the treatment of disease-related splenomegaly (enlarged spleen). It …
Recipharm announces closing of acquisitions of two major CDMOs
April 11, 2022Sales and Marketing
Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics. The acquisitions …
Innovative therapy ‘tricks’ and destroys cancer cells
April 11, 2022Sales and Marketing
A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients …
World leaders pledge $4.8 billion in 2022 Break COVID Now Summit
April 11, 2022Sales and Marketing
World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
